Human Bone Graft in Epiphysiodesis

Medical University of Vienna

Status: Enrolling

Conditions: Primordial Gigantism; Leg Length Differences

Treatments: Procedure: epiphysiodesis

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04067895

EP1

Details and patient eligibility

About

This observational study is to document the application of human bone graft in the surgical treatment (epiphysiodesis) of leg length discrepancy or primordial gigantism and its subsequent healing process.

Enrollment: 20 estimated patients

Sex: All

Ages: 10 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Planned epiphysiodesis to stop the growing of a bone indicated by leg length discrepancies or primordial gigantism
• Age 10-18 years
• Written consent to participate in the study after previous written and oral education (additional consent for the participation of minors in the study after prior written and oral education by at least one parent)

Exclusion criteria

• Insufficient knowledge of the german language
• Foreseeable compliance issues
• Neoplastic diseases, malignant bone tumors, rheumatoid arthritis
• Patients with non-treated pre-existing conditions, which could be the cause of leg length differences
• Active osteomyelitis
• Ulcerations in the area of the skin of the surgical area
• Immunosuppressive drugs that can not be discontinued

Trial design

20 participants in 1 patient group

human bone graft screw

Description:

human bone graft screws will be used during the epiphysiodesis

Treatment:

Procedure: epiphysiodesis